Last Close
May 15  •  04:00PM ET
2.42
Dollar change
+0.08
Percentage change
3.42
%
Index
-
P/E
-
EPS (ttm)
-0.21
Insider Own
46.67%
Shs Outstand
639.20M
Perf Week
-12.95%
Market Cap
1.55B
Forward P/E
3.03
EPS next Y
0.80
Insider Trans
-0.10%
Shs Float
340.90M
Perf Month
-11.36%
Enterprise Value
5.64B
PEG
0.29
EPS next Q
0.18
Inst Own
60.55%
Perf Quarter
33.70%
Income
-137.40M
P/S
0.63
EPS this Y
8.00%
Inst Trans
-4.49%
Perf Half Y
-30.26%
Sales
2.45B
P/B
0.32
EPS next Y
7.23%
ROA
-1.23%
Perf YTD
-27.54%
Book/sh
7.49
P/C
6.39
EPS next 5Y
10.42%
ROE
-2.80%
52W High
4.77 -49.27%
Perf Year
-43.85%
Cash/sh
0.38
P/FCF
4.63
EPS past 3/5Y
63.69% 16.31%
ROIC
-1.51%
52W Low
1.66 45.78%
Perf 3Y
-70.63%
Dividend Est.
-
EV/EBITDA
6.01
Sales past 3/5Y
-2.63% 14.38%
Gross Margin
35.66%
Volatility
7.63% 7.31%
Perf 5Y
-91.50%
Dividend TTM
-
EV/Sales
2.30
EPS Y/Y TTM
78.91%
Oper. Margin
7.45%
ATR (14)
0.19
Perf 10Y
-
Dividend Ex-Date
-
Quick Ratio
0.84
Sales Y/Y TTM
-3.25%
Profit Margin
-5.62%
RSI (14)
41.68
Dividend Gr. 3/5Y
- -
Current Ratio
0.84
EPS Q/Q
58.37%
SMA20
-8.85%
Beta
1.37
Payout
-
Debt/Eq
0.91
Sales Q/Q
-1.38%
SMA50
-5.30%
Rel Volume
0.64
Prev Close
2.34
Employees
12000
LT Debt/Eq
0.90
SMA200
-24.78%
Avg Volume
6.71M
Price
2.42
IPO
Oct 29, 2018
Option/Short
Yes / Yes
Trades
Volume
4,297,771
Change
3.42%
Date Action Analyst Rating Change Price Target Change
Jan-08-26Downgrade Goldman Buy → Neutral $3.60
Dec-17-25Downgrade Morgan Stanley Equal-Weight → Underweight $3
Sep-03-25Initiated Wolfe Research Peer Perform
Jul-18-25Initiated Jefferies Hold $4.50
Jul-18-25Downgrade Jefferies Buy → Hold $4.50
Nov-06-24Downgrade William Blair Outperform → Mkt Perform
Dec-15-23Downgrade Wells Fargo Equal Weight → Underweight $8
Oct-16-23Upgrade Jefferies Hold → Buy $10 → $8.50
Sep-08-23Downgrade Barclays Equal Weight → Underweight $8 → $7
Aug-25-23Downgrade RBC Capital Mkts Outperform → Sector Perform $9 → $8
May-06-26 03:00AM
May-04-26 11:41AM
May-01-26 09:45AM
Apr-29-26 12:46PM
08:55AM
06:00AM Loading…
06:00AM
Apr-28-26 03:00AM
Apr-15-26 09:00AM
Mar-26-26 04:00AM
Mar-25-26 07:35AM
Mar-10-26 08:54AM
04:00AM
Mar-04-26 12:20PM
08:00AM
Mar-03-26 03:23PM
02:11AM Loading…
Feb-28-26 02:11AM
Feb-27-26 12:43PM
Feb-25-26 10:46AM
Feb-24-26 04:32PM
04:22PM
04:00PM
01:56PM
01:04PM
09:30AM
07:35AM
06:00AM
Feb-13-26 05:59PM
Feb-09-26 09:14AM
08:00AM
Feb-05-26 12:59AM
01:18PM Loading…
Feb-03-26 01:18PM
08:00AM
Feb-02-26 07:30AM
Jan-29-26 12:25PM
Jan-28-26 08:00AM
Jan-22-26 03:00AM
Jan-21-26 03:00AM
Jan-20-26 07:46PM
Jan-06-26 03:07AM
Jan-02-26 10:50AM
Dec-31-25 11:41AM
Dec-28-25 12:46PM
Dec-21-25 07:40AM
Dec-18-25 03:00AM
Dec-11-25 11:40PM
Dec-08-25 11:52PM
Dec-04-25 03:00AM
Nov-24-25 03:00AM
Nov-21-25 05:02AM
Nov-13-25 11:37PM
08:15AM
03:00AM
Nov-12-25 03:03AM
Nov-06-25 03:00AM
Oct-30-25 03:51PM
09:24AM
04:03AM
Oct-29-25 09:30AM
07:10AM
06:00AM
Oct-28-25 09:41AM
Oct-22-25 05:54PM
Oct-13-25 09:57AM
Oct-07-25 09:28AM
03:00AM
Oct-06-25 08:30AM
Oct-01-25 03:00AM
Sep-30-25 04:59PM
02:49PM
Sep-25-25 03:00AM
Sep-22-25 12:22PM
Sep-19-25 02:49PM
Sep-18-25 04:18AM
Sep-16-25 12:13PM
Sep-04-25 08:00AM
Aug-31-25 12:16AM
Aug-27-25 03:00AM
Aug-26-25 11:29AM
Aug-14-25 10:00PM
03:00AM
Aug-12-25 11:42PM
Aug-08-25 07:30AM
Aug-04-25 01:36PM
10:02AM
Aug-01-25 08:30AM
Jul-31-25 11:18AM
03:19AM
Jul-30-25 09:30AM
07:10AM
06:01AM
06:00AM
Jul-29-25 09:38AM
Jul-23-25 12:30PM
Jul-22-25 05:15PM
11:13AM
Jul-11-25 11:05AM
Jul-09-25 03:29AM
Jul-08-25 07:30AM
Jul-06-25 03:48AM
Jun-30-25 02:52AM
Clarivate Plc engages in the provision of global information, analytics, and workflow solutions. It operates through the following segments: Academia and Government (A&G), Intellectual Property (IP), and Life Sciences and Healthcare (LS&H). The A&G segment involves the provision of research and analytics, content aggregation, and workflow software solutions using artificial intelligence. The IP segment includes the maintenance, intelligence, and management solutions. The LS&H focuses on solutions for research and development, regulatory and safety, and commercialization. The company was founded in 1864 and is headquartered in London, the United Kingdom.
CEO & DirectorMr. Matitiahu Shem Tov
President of Intellectual PropertyMr. Maroun S. Mourad
Senior VP & General CounselMr. John Doulamis
Senior VP & Head of PeopleMs. Darien Krimmert
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Veinstein BarPresident, A&GDec 01 '25Sale3.74309,9021,159,033848,811Dec 02 05:18 PM
BAR VEINSTEINOfficerDec 01 '25Proposed Sale3.74309,9021,160,273Dec 01 04:34 PM
Cornick Kenneth L.DirectorNov 10 '25Buy3.45100,000345,0001,100,000Nov 13 08:51 AM
Cornick Kenneth L.DirectorOct 31 '25Buy3.38500,0001,690,000775,000Nov 03 07:20 PM
Cornick Kenneth L.DirectorNov 03 '25Buy3.52225,000792,0001,000,000Nov 03 07:20 PM
Snyder Andrew MilesDirectorOct 31 '25Buy3.331,460,0004,861,8002,247,510Nov 03 05:16 PM
JAMES SAMSONOfficerSep 10 '25Proposed Sale4.26100,000426,370Sep 10 05:04 PM
Cornick Kenneth L.DirectorAug 01 '25Buy3.74165,000617,100275,000Aug 05 04:13 PM
Samson James GordonPresident, IPJul 01 '25Sale4.53100,000453,0001,271,103Jul 02 04:27 PM